HASSAN EMIL E 4
4 · NATIONAL HEALTHCARE CORP · Filed Oct 2, 2023
Insider Transaction Report
Form 4
HASSAN EMIL E
Director
Transactions
- Exercise/Conversion
Option to Purchase Common Stock [2020 Grant]
2023-09-29−2,000→ 5,500 totalExercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (7,500 underlying) - Exercise/Conversion
Shares of Common Stock
2023-09-29$64.64/sh+2,000$129,280→ 80,595 total
Holdings
- 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2021 Grant]
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).